Cargando…
CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents
Paeoniflorin-6′-O-benzene sulfonate (code: CP-25) was the chemistry structural modifications of Paeoniflorin (Pae). CP-25 inhibited B cells proliferation stimulated by B cell activating factor belonging to the TNF family (BAFF) or Tumor necrosis factor alpha (TNF-alpha). CP-25, Rituximab and Etanerc...
Autores principales: | Zhang, Feng, Shu, Jin-Ling, Li, Ying, Wu, Yu-Jing, Zhang, Xian-Zheng, Han, Le, Tang, Xiao-Yu, Wang, Chen, Wang, Qing-Tong, Chen, Jing-Yu, Chang, Yan, Wu, Hua-Xun, Zhang, Ling-Ling, Wei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743740/ https://www.ncbi.nlm.nih.gov/pubmed/29311935 http://dx.doi.org/10.3389/fphar.2017.00933 |
Ejemplares similares
-
CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response
por: Li, Nan, et al.
Publicado: (2022) -
CP-25 Attenuates the Activation of CD4(+) T Cells Stimulated with Immunoglobulin D in Human
por: Wu, Yu-jing, et al.
Publicado: (2018) -
A Modified Compound From Paeoniflorin, CP-25, Suppressed Immune Responses and Synovium Inflammation in Collagen-Induced Arthritis Mice
por: Chen, Jingyu, et al.
Publicado: (2018) -
Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis
por: Cai, Xiao-Yu, et al.
Publicado: (2020) -
The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6′-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases
por: Tu, Jiajie, et al.
Publicado: (2019)